Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. META
10. TLT

Go back to Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata
(NASDAQ: QTTB) Delayed: 10.86 -0.12 (1.09%)
Previous Close $10.98    52 Week High $ 
Open $11.14    52 Week Low $ 
Day High $11.17    P/E N/A 
Day Low $10.69    EPS $ 
Volume 383,980